183 related articles for article (PubMed ID: 15963623)
1. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study.
Patel MM; Belson MG; Wright D; Lu H; Heninger M; Miller MA
Resuscitation; 2005 Aug; 66(2):197-202. PubMed ID: 15963623
[TBL] [Abstract][Full Text] [Related]
2. Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
Kaye S; Darke S; Duflou J
Drug Alcohol Depend; 2009 Oct; 104(3):254-61. PubMed ID: 19604654
[TBL] [Abstract][Full Text] [Related]
3. Shedding new light on the "safe" club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities.
Patel MM; Wright DW; Ratcliff JJ; Miller MA
Acad Emerg Med; 2004 Feb; 11(2):208-10. PubMed ID: 14759969
[TBL] [Abstract][Full Text] [Related]
4. Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases.
Verschraagen M; Maes A; Ruiter B; Bosman IJ; Smink BE; Lusthof KJ
Forensic Sci Int; 2007 Aug; 170(2-3):163-70. PubMed ID: 17658708
[TBL] [Abstract][Full Text] [Related]
5. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.
Schifano F; Oyefeso A; Corkery J; Cobain K; Jambert-Gray R; Martinotti G; Ghodse AH
Hum Psychopharmacol; 2003 Oct; 18(7):519-24. PubMed ID: 14533133
[TBL] [Abstract][Full Text] [Related]
6. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
7. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
8. Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease.
Droogmans S; Cosyns B; D'haenen H; Creeten E; Weytjens C; Franken PR; Scott B; Schoors D; Kemdem A; Close L; Vandenbossche JL; Bechet S; Van Camp G
Am J Cardiol; 2007 Nov; 100(9):1442-5. PubMed ID: 17950805
[TBL] [Abstract][Full Text] [Related]
9. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study.
Murphy PN; Wareing M; Fisk J
J Psychopharmacol; 2006 May; 20(3):447-55. PubMed ID: 16574719
[TBL] [Abstract][Full Text] [Related]
10. Myocardial hypertrophy and coronary artery disease in male cocaine users.
Karch SB; Green GS; Young S
J Forensic Sci; 1995 Jul; 40(4):591-5. PubMed ID: 7595294
[TBL] [Abstract][Full Text] [Related]
11. Ecstasy (MDMA) deaths in New York City: a case series and review of the literature.
Gill JR; Hayes JA; deSouza IS; Marker E; Stajic M
J Forensic Sci; 2002 Jan; 47(1):121-6. PubMed ID: 12064638
[TBL] [Abstract][Full Text] [Related]
12. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
Falck RS; Wang J; Carlson RG
J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
[TBL] [Abstract][Full Text] [Related]
13. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users.
Verheyden SL; Henry JA; Curran HV
Hum Psychopharmacol; 2003 Oct; 18(7):507-17. PubMed ID: 14533132
[TBL] [Abstract][Full Text] [Related]
14. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities.
De Letter EA; Bouche MP; Van Bocxlaer JF; Lambert WE; Piette MH
Forensic Sci Int; 2004 May; 141(2-3):85-90. PubMed ID: 15062945
[TBL] [Abstract][Full Text] [Related]
15. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.
Silins E; Copeland J; Dillon P
Aust N Z J Psychiatry; 2007 Aug; 41(8):649-55. PubMed ID: 17620161
[TBL] [Abstract][Full Text] [Related]
16. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
17. Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females.
Cance JD; Ashley OS; Penne MA
J Adolesc Health; 2005 Nov; 37(5):409. PubMed ID: 16227128
[TBL] [Abstract][Full Text] [Related]
18. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
19. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
20. Club drug use in Germany.
Soellner R
Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
